MetLife Investment Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.58M | Sell |
|
|||||
|
2025
Q2 | $1.94M | Buy |
|
|||||
|
2025
Q1 | $1.94M | Sell |
|
|||||
|
2024
Q4 | $1.94M | Buy |
|
|||||
|
2024
Q3 | $2.86M | Buy |
|
|||||
|
2024
Q2 | $2.38M | Buy |
|
|||||
|
2024
Q1 | $953K | Hold |
|
|||||
|
2023
Q4 | $338K | Hold |
|
|||||
|
2023
Q3 | $238K | Hold |
|
|||||
|
2023
Q2 | $414K | Buy |
|
|||||
|
2023
Q1 | $527K | Buy |
|
|||||
|
2022
Q4 | $623K | Buy |
|
|||||
|
2022
Q3 | $418K | Hold |
|
|||||
|
2022
Q2 | $372K | Buy |
|
|||||
|
2022
Q1 | $358K | Buy |
|
|||||
|
2021
Q4 | $291K | Hold |
|
|||||
|
2021
Q3 | $302K | Hold |
|
|||||
|
2021
Q2 | $303K | Hold |
|
|||||
|
2021
Q1 | $267K | Buy |
|
|||||
|
2020
Q4 | $189K | Hold |
|
|||||
|
2020
Q3 | $208K | Buy |
|